IntoCell, Inc. (KOSDAQ:287840)
South Korea · Delayed Price · Currency is KRW
23,900
-500 (-2.05%)
At close: Aug 5, 2025, 3:30 PM KST
SpringWorks Therapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|
| Aug '25 Aug 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|
| 2.58 | 1.34 | 0.76 | 0.00 | 0.13 | 0.22 | |
| - | 0.12 | 0.06 | - | 0.00 | - | |
| 0.80 | 0.99 | 1.59 | 11.80 | 6.40 | 1.28 | |
| 0.80 | 1.00 | 1.63 | 11.96 | 6.42 | 1.29 | |
| -104.44% | -95.55% | -77.83% | -25.46% | -28.23% | -1307.60% | |
| - | -24.65% | -36.66% | -15.11% | -6.91% | -8.89% | |
| -29.62% | -29.98% | -40.88% | -16.16% | -10.57% | -76.53% | |
| -1.47% | -1.07% | 0.00% | -15.73% | -86.09% | -6.35% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.